Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study showed ...
Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis (MS) after a priority review by the US regulator. Tolebrutinib ...
Monarch Money targets people who want an ad-free, data-focused budgeting and net worth tracker that does not sell user data, ...
T-RGB 2.1 inch Half Circle ST7701S FT3267 T-RGB 2.1 inch Full Circle ST7701S CST820 T-RGB 2.8 inch Full Circle ST7701S GT911 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback